Annual Working Capital
$4.27 M
+$11.28 M+161.00%
June 30, 2024
Summary
- As of February 7, 2025, ESLA annual working capital is $4.27 million, with the most recent change of +$11.28 million (+161.00%) on June 30, 2024.
- During the last 3 years, ESLA annual working capital has risen by +$4.27 million (+100.00%).
- ESLA annual working capital is now at all-time high.
Performance
ESLA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$753.80 K
-$5.03 M-117.64%
September 30, 2024
Summary
- As of February 7, 2025, ESLA quarterly working capital is -$753.80 thousand, with the most recent change of -$5.03 million (-117.64%) on September 30, 2024.
- Over the past year, ESLA quarterly working capital has dropped by -$9.80 million (-108.33%).
- ESLA quarterly working capital is now -107.49% below its all-time high of $10.07 million, reached on September 30, 2023.
Performance
ESLA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ESLA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +161.0% | -108.3% |
| 3 y3 years | +100.0% | - |
| 5 y5 years | +100.0% | - |
ESLA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +161.0% | -107.5% | +89.2% |
| 5 y | 5-year | at high | +161.0% | -107.5% | +89.2% |
| alltime | all time | at high | +161.0% | -107.5% | +89.2% |
Estrella Immunopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$753.80 K(-117.6%) |
| Jun 2024 | $4.27 M | $4.27 M(-49.7%) |
| Mar 2024 | - | $8.49 M(-6.1%) |
| Dec 2023 | - | $9.05 M(-10.1%) |
| Sep 2023 | - | $10.07 M(-243.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$7.01 M(+332.8%) |
| Jun 2023 | -$7.01 M(-276.3%) | - |
| Dec 2022 | - | -$1.62 M |
| Jun 2022 | $3.98 M(>+9900.0%) | - |
| Jun 2021 | $0.00 | - |
FAQ
- What is Estrella Immunopharma annual working capital?
- What is the all time high annual working capital for Estrella Immunopharma?
- What is Estrella Immunopharma annual working capital year-on-year change?
- What is Estrella Immunopharma quarterly working capital?
- What is the all time high quarterly working capital for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly working capital year-on-year change?
What is Estrella Immunopharma annual working capital?
The current annual working capital of ESLA is $4.27 M
What is the all time high annual working capital for Estrella Immunopharma?
Estrella Immunopharma all-time high annual working capital is $4.27 M
What is Estrella Immunopharma annual working capital year-on-year change?
Over the past year, ESLA annual working capital has changed by +$11.28 M (+161.00%)
What is Estrella Immunopharma quarterly working capital?
The current quarterly working capital of ESLA is -$753.80 K
What is the all time high quarterly working capital for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly working capital is $10.07 M
What is Estrella Immunopharma quarterly working capital year-on-year change?
Over the past year, ESLA quarterly working capital has changed by -$9.80 M (-108.33%)